This study offers important insight into the pathogenic basis of intragenic frameshift deletions in the carboxy-terminal domain of MECP2, which account for some Rett syndrome cases, yet similar ...

A research team at Oregon Health & Science University has discovered a promising new drug combination that may help people with acute myeloid leukemia overcome resistance to one of the most common ...

A research team at Oregon Health & Science University has discovered a promising new drug combination that may help people with acute myeloid leukemia ...

Biopharma may see a happier year ahead in 2026 than in recent years, according to analysts at William Blair. For one thing, the industry’s top stocks have recovered from lows that stretched into last ...

India's hospital chains, diagnostics networks, and global investors have poured millions of dollars into gene sequencing, ...

With the MiSeq™ i100 Series, Illumina continues to set the highest standards. Advancements in system design, sequencing chemistry, and data analysis deliver the simplest, fastest benchtop sequencing ...

If you are looking at Illumina and wondering whether today’s price really reflects its long term potential, you are not alone; this stock has gone from market darling to question mark and back again ...

Scientists and physicians can better assess precision genome editing technology using a new method made public today by St.

Experiments on an ultra-rare genetic mutation that causes neurodegeneration in children have helped uncover a new mechanism ...

The Department of Bioengineering at UCSD has implemented the MassARRAY® system to conduct automated high throughput mutation detection in microbial genomes and mixed microbial populations. with the ...